Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
J Hepatol. 2020 Aug;73(2):328-341. doi: 10.1016/j.jhep.2020.03.025. Epub 2020 Mar 30.
J Hepatol. 2020.
PMID: 32240714
Free article.
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S, Armengol C, Maibach R, Häberle B, Becker K, Carrillo-Reixach J, Guettier C, Vokuhl C, Schmid I, Buendia MA, Branchereau S, von Schweinitz D, Kappler R.
Cairo S, et al. Among authors: carrillo reixach j.
Eur J Cancer. 2020 Dec;141:30-39. doi: 10.1016/j.ejca.2020.09.026. Epub 2020 Oct 27.
Eur J Cancer. 2020.
PMID: 33125945
Free article.
Item in Clipboard
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
Li Q, Demir S, Del Río-Álvarez Á, Maxwell R, Wagner A, Carrillo-Reixach J, Armengol C, Vokuhl C, Häberle B, von Schweinitz D, Schmid I, Cairo S, Kappler R.
Li Q, et al. Among authors: carrillo reixach j.
Cancers (Basel). 2022 Aug 30;14(17):4196. doi: 10.3390/cancers14174196.
Cancers (Basel). 2022.
PMID: 36077733
Free PMC article.
Item in Clipboard
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
Mosca N, Khoubai FZ, Fedou S, Carrillo-Reixach J, Caruso S, Del Rio-Alvarez A, Dubois E, Avignon C, Dugot-Senant N, Guettier C, Mussini C, Zucman-Rossi J, Armengol C, Thiébaud P, Veschambre P, Grosset CF.
Mosca N, et al. Among authors: carrillo reixach j.
Liver Cancer. 2021 Dec 21;11(2):126-140. doi: 10.1159/000521595. eCollection 2022 Apr.
Liver Cancer. 2021.
PMID: 35634422
Free PMC article.
Item in Clipboard
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines.
Corujo D, Malinverni R, Carrillo-Reixach J, Meers O, Garcia-Jaraquemada A, Le Pannérer MM, Valero V, Pérez A, Del Río-Álvarez Á, Royo L, Pérez-González B, Raurell H, Acemel RD, Santos-Pereira JM, Garrido-Pontnou M, Gómez-Skarmeta JL, Pasquali L, Manyé J, Armengol C, Buschbeck M.
Corujo D, et al. Among authors: carrillo reixach j.
Cell Rep. 2022 Jun 21;39(12):110988. doi: 10.1016/j.celrep.2022.110988.
Cell Rep. 2022.
PMID: 35732123
Free article.
Item in Clipboard
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.
Failli M, Demir S, Del Río-Álvarez Á, Carrillo-Reixach J, Royo L, Domingo-Sàbat M, Childs M, Maibach R, Alaggio R, Czauderna P, Morland B, Branchereau S, Cairo S, Kappler R, Armengol C, di Bernardo D.
Failli M, et al. Among authors: carrillo reixach j.
Hepatology. 2023 Sep 20. doi: 10.1097/HEP.0000000000000601. Online ahead of print.
Hepatology. 2023.
PMID: 37729391
Item in Clipboard
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Abril-Fornaguera J, Torrens L, Andreu-Oller C, Carrillo-Reixach J, Rialdi A, Balaseviciute U, Pinyol R, Montironi C, Haber PK, Del Río-Álvarez Á, Domingo-Sàbat M, Royo L, Akers NK, Willoughby CE, Peix J, Torres-Martin M, Puigvehi M, Cairo S, Childs M, Maibach R, Alaggio R, Czauderna P, Morland B, Losic B, Mazzaferro V, Guccione E, Sia D, Armengol C, Llovet JM.
Abril-Fornaguera J, et al. Among authors: carrillo reixach j.
Mol Cancer Ther. 2023 Apr 3;22(4):485-498. doi: 10.1158/1535-7163.MCT-22-0335.
Mol Cancer Ther. 2023.
PMID: 36780225
Free PMC article.
Item in Clipboard
Cite
Cite